Quantum-Si (NASDAQ:QSI) CEO Sells $17,880.24 in Stock

Key Points

• Quantum-Si CEO Jeffrey Alan Hawkins sold 10,643 shares at an average price of $1.68, totaling $17,880.24, reducing his stake to 2,612,368 shares.
• The company's shares are currently trading around $1.61, with a market capitalization of $326.01 million and a P/E ratio of -2.37.
• Analysts have set a consensus price target of $3.48 for Quantum-Si, with a mix of buy and hold ratings among research analysts.

Quantum-Si Incorporated (NASDAQ:QSI - Get Free Report) CEO Jeffrey Alan Hawkins sold 10,643 shares of the business's stock in a transaction that occurred on Monday, September 22nd. The shares were sold at an average price of $1.68, for a total value of $17,880.24. Following the transaction, the chief executive officer owned 2,612,368 shares of the company's stock, valued at $4,388,778.24. This trade represents a 0.41% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Quantum-Si Price Performance

Shares of NASDAQ:QSI traded up $0.01 during trading hours on Wednesday, hitting $1.61. 13,158,037 shares of the company's stock traded hands, compared to its average volume of 11,405,648. The business has a fifty day moving average price of $1.35 and a 200-day moving average price of $1.45. The firm has a market capitalization of $326.01 million, a P/E ratio of -2.37 and a beta of 2.85. Quantum-Si Incorporated has a 1 year low of $0.61 and a 1 year high of $5.77.

Quantum-Si (NASDAQ:QSI - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported ($0.16) EPS for the quarter, meeting the consensus estimate of ($0.16). Quantum-Si had a negative return on equity of 44.57% and a negative net margin of 3,120.14%.The firm had revenue of $0.59 million during the quarter, compared to analyst estimates of $1.28 million. As a group, equities analysts predict that Quantum-Si Incorporated will post -0.65 earnings per share for the current year.

Institutional Trading of Quantum-Si

Several institutional investors have recently made changes to their positions in the company. Millennium Management LLC purchased a new stake in shares of Quantum-Si during the 1st quarter valued at approximately $4,721,000. Geode Capital Management LLC increased its holdings in Quantum-Si by 15.1% in the 2nd quarter. Geode Capital Management LLC now owns 3,447,738 shares of the company's stock valued at $6,759,000 after purchasing an additional 452,850 shares during the last quarter. Bank of America Corp DE increased its holdings in Quantum-Si by 426.6% in the 2nd quarter. Bank of America Corp DE now owns 465,999 shares of the company's stock valued at $913,000 after purchasing an additional 377,504 shares during the last quarter. XTX Topco Ltd increased its holdings in Quantum-Si by 50.2% in the 1st quarter. XTX Topco Ltd now owns 368,968 shares of the company's stock valued at $443,000 after purchasing an additional 123,383 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its holdings in Quantum-Si by 19.3% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 367,444 shares of the company's stock valued at $441,000 after purchasing an additional 59,423 shares during the last quarter. Hedge funds and other institutional investors own 39.90% of the company's stock.

Analysts Set New Price Targets

Separately, Canaccord Genuity Group reissued a "hold" rating and set a $1.00 target price on shares of Quantum-Si in a research note on Tuesday, September 9th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, Quantum-Si currently has a consensus rating of "Moderate Buy" and a consensus price target of $3.48.

Quantum-Si Company Profile

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.